Literature DB >> 9323470

Plasma interleukin-8, interleukin-10, and E-selectin levels in neutropenic and non-neutropenic bacteremic patients.

M Hynninen1, M Valtonen, M Vaara, H Markkanen, P Kuusela, H Saxen, O Takkunen.   

Abstract

Plasma interleukin-8 (IL-8) interleukin-10 (IL-10), and E-selectin concentrations were studied in 39 neutropenic and 30 non-neutropenic bacteremic patients; 54 nonbacteremic patients were analyzed as controls. Interleukin-8 concentrations were significantly higher in neutropenic than in non-neutropenic bacteremic patients (median 475 vs. 0 pg/ml, p < 0.0001). Median IL-8 and IL-10 levels were higher in bacteremic than in non-bacteremic patients (330 vs. 0 pg/ml, p < 0.0001 and 20 vs. 0 pg/ml, p = 0.04, respectively). In contrast, concentrations of IL-10 were similar in neutropenic and non-neutropenic patients. Median levels of E-selectin were not increased in any of the patient groups. Neutropenic bacteremic patients showed significantly lower concentrations of E-selectin than did non-neutropenic bacteremic patients (p < 0.0001). In conclusion, neutropenic bacteremic patients had significantly higher concentrations of IL-8 than non-neutropenic bacteremic patients. Levels of IL-10 were higher in bacteremic than in nonbacteremic patients, but neutropenic and non-neutropenic patients had similar levels of IL-10. Increased levels of E-selectin were not found in any of the patient groups, although neutropenic patients with bacteremia had lower concentrations than did non-neutropenic patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323470     DOI: 10.1007/BF02447921

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   5.103


  18 in total

Review 1.  Leucocyte-endothelial interactions and regulation of leucocyte migration.

Authors:  D H Adams; S Shaw
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

2.  Regulation of transendothelial neutrophil migration by endogenous interleukin-8.

Authors:  A R Huber; S L Kunkel; R F Todd; S J Weiss
Journal:  Science       Date:  1991-10-04       Impact factor: 47.728

3.  Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

Authors:  M B Lawrence; T A Springer
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

4.  Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients.

Authors:  J Boldt; M Muller; D Kuhn; L C Linke; G Hempelmann
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

5.  Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients.

Authors:  M Hynninen; M Valtonen; M Vaara; H Markkanen; P Kuusela; H Saxen; O Takkunen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

Review 6.  Pathogenesis and potential strategies for prevention and treatment of septic shock: an update.

Authors:  M P Glauser; D Heumann; J D Baumgartner; J Cohen
Journal:  Clin Infect Dis       Date:  1994-02       Impact factor: 9.079

7.  High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock.

Authors:  B Derkx; A Marchant; M Goldman; R Bijlmer; S van Deventer
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

8.  Interleukin-10 production during septicaemia.

Authors:  A Marchant; J Devière; B Byl; D De Groote; J L Vincent; M Goldman
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

9.  Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans.

Authors:  D B Kuhns; W G Alvord; J I Gallin
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

10.  Interleukin 10 protects mice from lethal endotoxemia.

Authors:  M Howard; T Muchamuel; S Andrade; S Menon
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  1 in total

1.  Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?

Authors:  Sophie Ohlsson; Jörgen Wieslander; Mårten Segelmark
Journal:  Mediators Inflamm       Date:  2004-08       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.